TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
3 hedge funds and large institutions have $1.54M invested in TrovaGene, Inc. Warrant in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
1,582% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $88K
0% more funds holding
Funds holding: 3 → 3 (0)
48% less capital invested
Capital invested by funds: $2.94M → $1.54M (-$1.4M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$541 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.68K |
| 2 |
Morgan Stanley
New York
|
-$3.79K |
TROVW Hedge Fund Activity: Q4 2015 in Review
3 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q4 2015, worth a combined $1.54M — down 48% from $2.94M a quarter earlier.
Fund positioning in TROVW was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $541. The largest seller was Millennium Management, cutting an estimated $5.68K.
- 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $1.54M of TrovaGene, Inc. Warrant stock for Q4 2015, down 48% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q4 2015 and 0 closed out.
- The largest TrovaGene, Inc. Warrant buyer in Q4 2015 was Tower Research Capital (TRC), an estimated $541 added.
- The largest TrovaGene, Inc. Warrant seller in Q4 2015 was Millennium Management, an estimated $5.68K sold.
Based on aggregated 13F filings for Q4 2015.